- Home
- CELU vs GEG Comparison
CELU vs GEG Comparison
Compare CELU & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- GEG
- Stock Information
- Founded
- CELU 2016
- GEG 1994
- Country
- CELU United States
- GEG United States
- Employees
- CELU N/A
- GEG N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- GEG Computer Software: Prepackaged Software
- Sector
- CELU Health Care
- GEG Technology
- Exchange
- CELU Nasdaq
- GEG Nasdaq
- Market Cap
- CELU 49.9M
- GEG 52.4M
- IPO Year
- CELU N/A
- GEG N/A
- Fundamental
- Price
- CELU $2.24
- GEG $1.84
- Analyst Decision
- CELU
- GEG
- Analyst Count
- CELU 0
- GEG 0
- Target Price
- CELU N/A
- GEG N/A
- AVG Volume (30 Days)
- CELU 231.0K
- GEG 55.0K
- Earning Date
- CELU 11-07-2024
- GEG 02-11-2025
- Dividend Yield
- CELU N/A
- GEG N/A
- EPS Growth
- CELU N/A
- GEG N/A
- EPS
- CELU N/A
- GEG N/A
- Revenue
- CELU $48,200,000.00
- GEG $18,516,000.00
- Revenue This Year
- CELU N/A
- GEG N/A
- Revenue Next Year
- CELU $233.89
- GEG N/A
- P/E Ratio
- CELU N/A
- GEG N/A
- Revenue Growth
- CELU 225.94
- GEG 83.09
- 52 Week Low
- CELU $1.30
- GEG $1.70
- 52 Week High
- CELU $7.97
- GEG $2.12
- Technical
- Relative Strength Index (RSI)
- CELU 46.60
- GEG 53.59
- Support Level
- CELU $2.17
- GEG $1.76
- Resistance Level
- CELU $2.43
- GEG $1.88
- Average True Range (ATR)
- CELU 0.26
- GEG 0.03
- MACD
- CELU -0.01
- GEG 0.00
- Stochastic Oscillator
- CELU 54.02
- GEG 85.71
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.